Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moderate-intensity statin plus ezetimibe vs high-intensity statin for coronary plaque regression after PCI
KCT0003431Phase 4Completed
- Sponsor
- Chong Kun Dang
- Start
- Mar 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe, ulinastatin in coronary arteriosclerosis, sponsored by Chong Kun Dang. Started Mar 2017; status: completed.
02
Drugs
ezetimibeulinastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on KCT0003431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003431.